Volume 47, Issue 4 pp. 660-668
ORIGINAL ARTICLE

Assessment of the Use of Available Resources for Diagnosing Diffuse Large B-Cell Lymphoma in an HIV-Prevalent Setting

Gaone Abigail Moalosi

Gaone Abigail Moalosi

Department of Molecular Medicine and Haematology, University of Witwatersrand Medical School and National Health Laboratory Service, Johannesburg, Gauteng, South Africa

Search for more papers by this author
Jenifer Vaughan

Jenifer Vaughan

Department of Molecular Medicine and Haematology, University of Witwatersrand Medical School and National Health Laboratory Service, Johannesburg, Gauteng, South Africa

Search for more papers by this author
Elise Schapkaitz

Corresponding Author

Elise Schapkaitz

Department of Molecular Medicine and Haematology, University of Witwatersrand Medical School and National Health Laboratory Service, Johannesburg, Gauteng, South Africa

Correspondence:

Elise Schapkaitz ([email protected])

Search for more papers by this author
First published: 06 March 2025

Funding: The authors received no specific funding for this work.

ABSTRACT

Background

Limited availability of diagnostic tests in low-resource settings hampers the diagnosis and classification of diffuse large B-cell lymphoma (DLBCL). A study was performed to assess the use of resources for classifying DLBCL in South Africa (SA) using ‘essential’ and ‘desirable’ investigations as per published guidelines.

Methods

A record review was performed of 74 patients newly diagnosed with DLBCL by tissue biopsy at the National Health Laboratory Service (NHLS) in Johannesburg between 1 January 2019 and 31 December 2022. The immunohistochemistry (IHC) and/or molecular work-up performed for the primary diagnosis of DLBCL and the associated costs were recorded.

Results

The primary diagnosis of DLBCL was based on 34 (45.9%) nodal and 40 (54.1%) extra-nodal biopsy sections. Overall, 60 (81.1%) were from participants living with human immunodeficiency virus (HIV) infection. ‘Essential’ IHC for CD3, CD10, CD20, Ki-67, BCL-2, BCL-6, MUM-1 and ‘desirable’ fluorescence in situ hybridisation (FISH) for MYC gene rearrangement were most requested for diagnosis. ‘Essential’ IHC for c-MYC was not performed because of non-availability of the testing. The ‘essential’ IHC was diagnostic in 97.3%. ‘Desirable’ FISH for MYC rearrangement was done in 56 (79.7%) cases, with additional FISH for BCL2 and BCL6 rearrangement performed in cases positive for MYC rearrangement. The average cost of diagnosis at the NHLS was half that of the recommended diagnostic testing.

Conclusion

The advocated ‘essential’ investigations, in addition to ‘desirable’ tests where necessary, enabled the accurate and cost-effective diagnosis of DLBCL in SA and are recommended for other parts of the world with limited resources.

Conflicts of Interest

The authors declare no conflicts of interest.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.